Exodus Point Capital Management, LP Seres Therapeutics, Inc. Transaction History

Exodus Point Capital Management, LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	BUY	$2.33 - $5.07 $327,977 - $713,668	140,763 Added 23.66%	735,658 $1.75 Million
Q2 2023 Aug 10, 2023	BUY	$4.67 - $6.55 $2.78 Million - $3.9 Million	594,895 New	594,895 $2.85 Million
Q4 2022 Feb 13, 2023	BUY	$5.09 - $9.05 $219,908 - $390,996	43,204 New	43,204 $242,000
Q3 2022 Nov 10, 2022	SELL	$3.5 - $7.2 $58,093 - $119,505	-16,598 Closed	0 $0
Q2 2022 Aug 19, 2022	SELL	$2.7 - $7.62 $297,858 - $840,623	-110,318 Reduced 86.92%	16,598 $57,000
Q1 2022 May 13, 2022	BUY	$6.3 - $8.84 $246,273 - $345,564	39,091 Added 44.51%	126,916 $904,000
Q4 2021 Feb 11, 2022	BUY	$6.02 - $11.43 $528,706 - $1 Million	87,825 New	87,825 $732,000
Q1 2021 May 17, 2021	SELL	$17.66 - $28.92 $823,344 - $1.35 Million	-46,622 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$23.25 - $37.73 $1.08 Million - $1.76 Million	46,622 New	46,622 $1.14 Million

40.5M

304K

471K

Ticker MCRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,072,000
Market Cap $68.2M
Description
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.